| Literature DB >> 2437268 |
F Khafagi, J Egerton-Vernon, T van Doorn, W Foster, I B McPhee, R W Allison.
Abstract
Two cases of familial, malignant, nonfunctional paraganglioma are reported. Uptake of iodine-131 metaiodobenzylguanidine ([131I]MIBG) by the tumors and metastases was demonstrated. In the first case, with multicentric and locally invasive disease, [131I]MIBG correctly localized a right carotid body paraganglioma which had been missed arteriographically. In the second case, with widespread, symptomatic metastatic disease, a therapeutic dose of [131I]MIBG produced palliation of bone pain after the failure of radio- and chemotherapy. Uptake of [131I]MIBG by paragangliomas does not correlate with catecholamine secretory activity. Iodine-131 MIBG should be considered as a therapeutic option in unresectable, malignant paragangliomas which take up this radiopharmaceutical.Entities:
Mesh:
Substances:
Year: 1987 PMID: 2437268
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057